Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Jackson

Showing results (481-490 of 517) with videos related to

Pageof 52
Sort By:
Australian Paediatric Journal|January 1, 1988
Increased pro-opiomelanocortin-derived peptide release in myotonic dystrophyR V Jackson, G A Fleming, C R Sussman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical trial of folinic acid to reduce vincristine neurotoxicityD V Jackson, R A McMahan, E K Pope, et al.
Scandinavian Journal of Haematology. Supplementum|January 1, 1986
Dose-related pharmacologic effects of high dose ara-C and its use in combination with asparaginase for the treatment of patients with acute non-lymphocytic leukemiaR L Capizzi, B L Powell, M R Cooper, et al.
Chest|August 1, 1989
Utility of the Wang 18-gauge transbronchial histology needle in the staging of bronchogenic carcinomaD A Schenk, P J Strollo, J S Pickard, et al.
Journal of Neuro-Oncology|January 1, 1984
Improved tolerance of vincristine by glutamic acid. A preliminary reportD V Jackson, E K Pope, L D Case, et al.
Journal of Neuro-Oncology|January 1, 1986
Clinical trial of pyridoxine to reduce vincristine neurotoxicityD V Jackson, E K Pope, R A McMahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association studyH B Muss, L D Case, J N Atkins, et al.
Current Obstetrics and Gynecology Reports|August 27, 2016
Caring for Pregnant Women with Opioid Use Disorder in the USA: Expanding and Improving TreatmentKelley A Saia, Davida Schiff, Elisha M Wachman, et al.
Cancer|December 1, 1982
Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer: a randomized trial of the Piedmont Oncology AssociationH B Muss, F Richards, D V Jackson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1999
Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonismA S Mandir, S Przedborski, V Jackson-Lewis, et al.
Pageof 52

Showing results (481-490 of 517) with videos related to

Sort By:
Pageof 52
Australian Paediatric Journal|January 1, 1988
Increased pro-opiomelanocortin-derived peptide release in myotonic dystrophyR V Jackson, G A Fleming, C R Sussman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical trial of folinic acid to reduce vincristine neurotoxicityD V Jackson, R A McMahan, E K Pope, et al.
Scandinavian Journal of Haematology. Supplementum|January 1, 1986
Dose-related pharmacologic effects of high dose ara-C and its use in combination with asparaginase for the treatment of patients with acute non-lymphocytic leukemiaR L Capizzi, B L Powell, M R Cooper, et al.
Chest|August 1, 1989
Utility of the Wang 18-gauge transbronchial histology needle in the staging of bronchogenic carcinomaD A Schenk, P J Strollo, J S Pickard, et al.
Journal of Neuro-Oncology|January 1, 1984
Improved tolerance of vincristine by glutamic acid. A preliminary reportD V Jackson, E K Pope, L D Case, et al.
Journal of Neuro-Oncology|January 1, 1986
Clinical trial of pyridoxine to reduce vincristine neurotoxicityD V Jackson, E K Pope, R A McMahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association studyH B Muss, L D Case, J N Atkins, et al.
Current Obstetrics and Gynecology Reports|August 27, 2016
Caring for Pregnant Women with Opioid Use Disorder in the USA: Expanding and Improving TreatmentKelley A Saia, Davida Schiff, Elisha M Wachman, et al.
Cancer|December 1, 1982
Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer: a randomized trial of the Piedmont Oncology AssociationH B Muss, F Richards, D V Jackson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1999
Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonismA S Mandir, S Przedborski, V Jackson-Lewis, et al.
Pageof 52